Poly Medicure Q1 Results Review - On Path To Achieve Accelerated Growth: Systematix
The brokerage downgrades to 'Hold' considering the recent run up in stock price25-07-2024
25-07-2024
POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to the provisions of Regulation 30 and 46(2) (oa) of the securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended, the audio recording of the Earnings Conference Call held on Wednesday, July 24th, 2024, on the Unaudited Standalone and Consolidated financial results of the Company for the quarter ended on June 30, 2024, is available on the Company's website at https://www.polymedicure.com/wp-content/uploads/2024/07/ICI3420240724154379.mp324-07-2024
POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30, Regulation 51 and other applicable provisions of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the investor''s presentation with respect to Un-audited Financial Results for the first quarter ended on June 30, 2024.24-07-2024
POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), the Board of directors in its meeting held on today i.e. Monday, July 22, 2024 has appointed vimal Bhandari (DIN: 0001318) as an additional- Non Executive, Independent Director of the Company with effect from 22nd July, 2024, subject to approval of shareholders at the ensuing general meeting of the Company.22-07-2024
POLY MEDICURE LTD. - 531768 - Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June, 2024 In Compliance Of Regulation 30 And 33 Of SEBI (LODR) Regulations, 2015
Unaudited Financial Results ( Standalone & Consolidated) for the quarter ended on 30th June, 2024 in compliance of Regulation 30 and 33 of SEBI (LODR) Regulations, 201522-07-2024
POLY MEDICURE LTD. - 531768 - Board Meeting Outcome for Outcome Of The Board Meeting Of The Company In Compliance Of Regulation 30 And 33 Of SEBI (LODR) Regulations, 2015
Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, we are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 22nd July, 2024 232-B, 3rd Floor, Okhla Industrial Estate, Phase-III, New Delhi-110020, approved the following businesses: a) Unaudited Financial Results (Consolidate & Standalone) for the first quarter ended on 30th June 2024. b) To Re-appoint and Ratification of Remuneration of M/s. Jai Prakash & Company, Cost Accountants as Cost Auditors of the Company for the Financial Year 2024-25, subject to the approval of the shareholders in the forthcoming Annual General Meeting. c) To appoint Mr. Vimal Bhandari (DIN 0001318), as Non-Executive and Independent Director on the Board of the Company, subject to shareholder approval in upcoming Annual general meeting.22-07-2024
POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an earnings call will be held on Wednesday, 24th July, 2024 at 4.00 p.m. (IST) for discussing the Unaudited Financial Results of the Company for the quarter ended 30th June, 2024. Link for joining, Dial in and other details of the call are enclosed herewith. ICICI Securities Limited through its representatives along with Company's officials will coordinate the aforesaid meeting. This is for your information and record.19-07-2024
POLY MEDICURE LTD. - 531768 - Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On 22Nd July, 2024
POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/07/2024 ,inter alia, to consider and approve Dear Sir/Madam, Pursuant to Regulation 29(1)(a) of the SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, notice is hereby given that a meeting of the Board of Director of the Company will be held on Monday, the 22nd July, 2024, inter alia to consider the following: a. To consider and approve the Unaudited Financial Results (Consolidated & Standalone) of the company for the First Quarter ended 30th June, 2024. b. To transact any other matter which the Board may deem fit. In continuation of our intimation regarding closure of trading window vide letter dated 29th June, 2024, the Trading Window for dealing in securities of the company shall remain closed till 24th July, 2024.17-07-2024
POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Demise
The Company regrets to inform about the sad demise of Mr. Prakash Chand Surana (DIN: 00361485), Non-Executive Independent Director of the Company on Wednesday, 17th July, 2024 which has intimated to the Company by the family member of Mr. Prakash Chand Surana today (i.e. 17th July, 2024) We request you to take the above intimation on your record in Compliance with Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015.17-07-2024
POLY MEDICURE LTD. - 531768 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In terms of Regulation 74(5) of SEBI(Depositories and Participants) Regulations, 2018, we enclose herewith confirmation certificated received from M/s Mas Services Limited, Registrar and Share Transfer Agent of the Company For the Quarter ended 30th June, 2024.15-07-2024